Abstract

It has been reported that the ACE-inhibitor related cough is less with imidapril than with some other ACE-inhibitors. Aim of this study was to evaluate whether treatment with imidapril reduce cough induced by ramipril and to evaluate the effect of addition of indomethacin, a known inhibitor of prostaglandins synthesis, to the 2 ACE-inhibitors on cough frequency and intensity. After 1 week placebo period 84 hypertensive patients who developed cough during chronic ramipril treatment were randomized to ramipril 10 mg or imidapril 20 mg for 8 weeks. Subsequently patients still complaining cough continued the respective ACE-inhibitor treatment, but in each arm they were allocated to receive also indomethacin 50 mg twice daily or placebo twice daily for 4 weeks according to a double masked, double dummy, cross-over design. At the end of each phase of the study cough was assessed by means of a self-administrated questionnaire with an ordinal 10-point visual analogue scale for rating daily cough intensity and frequency. At the end of the 8 weeks monotherapy phase 41 of 42 (98%) patients randomized to ramipril complained cough, while among the patients randomized to imidapril cough was complained by 23 of the 42 patients (55%), the difference between the 2 groups being statistically significant (p < 0.01). Indomethacin addition eliminated cough in 20% of patients in ramipril group and in 22% of patients in imidapril group while reduced cough intensity and frequency in 51% of patients in ramipril group and in 52% of patients in imidapril group; no significant difference was observed between the 2 treatment groups. These results indicate that incidence of cough is lower with imidapril than with ramipril and that prostaglandins play a role in the cough induced by ACE-inhibitors. The finding that the effect of indomethacin is the same with the 2 ACE-inhibitors suggests that the lower incidence of cough observed with imidapril is mediated by same mechanism independent of prostaglandin synthesis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call